LANCASTER, Calif.--(BUSINESS WIRE)--Words+, Inc., a leading provider of augmentative communication and assistive technology hardware and software for people with disabilities, announced today that it has launched EyePro GS™, a new product designed and manufactured in-house that allows a person to operate an augmentative communication system or computer by simply looking at the screen. Words+ is a wholly owned subsidiary of Simulations Plus, Inc. (NASDAQ: SLP).
Jeff Dahlen, president of Words+, said: “We’ve been working on our own proprietary design for about two years, and we have achieved and exceeded our internal product performance objectives, including our goals for ease of setup and use. EyePro GS™ is a major achievement by our engineering department that required the integration of a complex series of hardware and software design decisions. The new EyePro GS includes Guided Calibration™ and Access Styles™, which contain features not found in other eye gaze systems. It significantly improves our margin, allows us to add proprietary features, secures our participation in the eye gaze industry, and allows us to sell multiple solutions in order to serve a larger customer base. While there is some overlap of functionality between the various eye gaze products we offer, each product embodies unique hardware and software features and mathematical algorithms. These differences will appeal to particular clients based on how the unit meets their specific physical needs within their communication environment, and will appeal to buyers’ personal preferences based on the overall look and feel of the products. With this extension of our eye gaze product line, we’re excited to be able to enter competitive client engagements with multiple eye gaze solutions.”
Gaylon Ponder, national sales manager for Words+, added: “Introducing EyePro GS adds important new, sellable features to the eye gaze industry such as easier, more stable setup, increased client productivity, reduced fatigue, and ease of portability between home, school and work environments. We set the goal that EyePro GS would not be just another eye gaze, and our engineers provided more accessibility to advanced adjustments and diagnostic screens than our competitors. I expect EyePro GS to significantly increase our sales of both eye gaze and communication systems, and to expand the eye gaze market in general as people experience better eye gaze success with EyePro GS than in past attempts with competing products. I am pleased to go to market with a product that is superbly functional, with advanced features to benefit people who use their eyes to communicate or operate computers.”
About Words+, Inc.
Words+ is a leading developer of hardware and software technologies for the disabled. Founded in 1981, Words+ has provided augmentative communication (speech output) and assistive technology devices for 30 years to thousands of people worldwide. Words+ is a nationwide Medicare, Medicaid, and private insurance provider. World-famous theoretical astrophysicist Professor Stephen W. Hawking of the University of Cambridge in England has been using Words+ computer-based communication technology to prepare, publish, and present worldwide since 1985. Words+ is a wholly owned subsidiary of Simulations Plus, Inc. (NASDAQ: SLP).
About Simulations Plus, Inc.
Simulations Plus, Inc. is a premier developer of groundbreaking drug discovery and development simulation and modeling software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. The Company’s Words+, Inc. wholly owned subsidiary provides augmentative communication systems and other technologies for persons with disabilities. Simulations Plus, Inc. is headquartered in Southern California. For more information, visit our web site at www.simulations-plus.com.
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995 – With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of the Company could differ significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to: the market acceptance of EyePro and continued acceptance of the other products of the Company, the ability of the Company to maintain its competitive advantage, the general economics of the pharmaceutical and assistive technology industries, the ability of the Company to attract and retain sufficient scientific and technical staff to sustain its R&D and customer support functions, the continued high renewal rate for the Company’s software licenses, and a sustainable market. Further information on the Company’s risk factors is contained in the Company’s quarterly and annual reports as filed with the Securities and Exchange Commission.